FBR Limited (ASX:FBR) Ends Joint Venture Option with CRH Ventures
FBR Limited (ASX:FBR) concludes joint venture option with CRH Ventures, achieving key operational milestones and planning future growth in the US.
Rox Resources (ASX:RXL) Announces Youanmi Drilling Program Update
Rox Resources (ASX:RXL) reports significant assay results and operational progress in its 35,000m Youanmi drilling campaign.
White Cliff Minerals Limited (ASX:WCN) Commences Drilling at Rae Copper Project
White Cliff Minerals Limited (ASX:WCN) begins drilling at Rae Copper Project in Nunavut, initiating its first major exploration effort in the region in over a decade.
Pengana International Equities Limited (ASX:PIA) Announces Half-Year Results
Pengana International Equities Limited (ASX:PIA) reports a 202% increase in profit and declares two interim dividends for the half-year ended 31 December 2024.
Carbonxt Group Limited (ASX:CG1) Launches Share Purchase Plan
Carbonxt Group Limited (ASX:CG1) launches a Share Purchase Plan to raise up to $2 million, supporting its Kentucky facility development and positioning for growth.
Cyclone Metals (ASX:CLE) & Vale Sign Iron Bear Agreement
Cyclone Metals (ASX:CLE) and Vale sign a development agreement for the Iron Bear Project, securing up to USD138M in funding.
ACORN CAPITAL INVESTMENT FUND LIMITED (ASX:ACQ) Suspended from Quotation
ACORN CAPITAL INVESTMENT FUND LIMITED (ASX:ACQ) is suspended from quotation for not lodging the required periodic report by the due date.
Toys”R”Us ANZ Limited (ASX:TOY) Secures Strategic Partnership with Directed Electronics
Toys”R”Us ANZ Limited (ASX:TOY) enters a strategic partnership with Directed Electronics to co-develop products and expand its product portfolio.
Aruma Resources Ltd (ASX:AAJ) Announces Multiple High-Grade Gallium Assay Results
Aruma Resources (ASX:AAJ) announces multiple high-grade gallium assay results from its Saltwater Project in Pilbara, highlighting strong exploration potential.
Neurizon Therapeutics Limited (ASX:NUZ) Receives FDA Guidance on NUZ-001 IND Application
Neurizon Therapeutics Limited (ASX:NUZ) receives FDA guidance on its IND application for NUZ-001, requesting additional animal exposure data.